Detalhe da pesquisa
1.
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments.
Hepatology
; 77(5): 1566-1579, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941803
2.
Reply: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy.
Hepatology
; 79(4): E125-E126, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147327
3.
Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis.
Ann Surg Oncol
; 23(11): 3684-3692, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27221363
4.
Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort.
Cancer
; 121(4): 580-8, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25302685
5.
Spatial Mass Cytometry-Based Single-Cell Imaging Reveals a Disrupted Epithelial-Immune Axis in Prurigo Nodularis.
J Invest Dermatol
; 2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38522569
6.
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer.
Cell Rep Med
; 5(2): 101397, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307029
7.
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.
Cancer Immunol Res
; 12(4): 400-412, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260999
8.
Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis.
J Invest Dermatol
; 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246584
9.
Systems immunology spanning tumors, lymph nodes, and periphery.
Cell Rep Methods
; 3(12): 100670, 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38086385
10.
CyTOF protocol for immune monitoring of solid tumors from mouse models.
STAR Protoc
; 4(1): 101949, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538397
11.
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma.
Cancer Res Commun
; 3(7): 1312-1317, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37484200
12.
Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trial.
bioRxiv
; 2023 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645761
13.
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma models.
bioRxiv
; 2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961529
14.
Single-cell RNA sequencing reveals dysregulated fibroblast subclusters in prurigo nodularis.
bioRxiv
; 2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778229
15.
Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy.
bioRxiv
; 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747853
16.
Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis.
Healthcare (Basel)
; 11(18)2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37761768
17.
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors.
J Clin Oncol
; 41(12): 2181-2190, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623241
18.
Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces.
Cell Syst
; 14(4): 285-301.e4, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080163
19.
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade.
bioRxiv
; 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904980
20.
Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma.
Front Immunol
; 13: 892250, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634309